NCT03071406 2026-03-11
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
Pfizer
Istanbul Training and Research Hospital